Jiřı́ Mayer

1. Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
   2018/09/07 by Wojciech Jurczak, Krzysztof Chojnowski, Jiřı́ Mayer +6 · 30 citations
   Medicine · #Platelet Disorders and Treatments #Blood groups and transfusion #Blood properties and coagulation
2. Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
   2016/03/04 by William V. Padula, Richard A. Larson, Stacie B. Dusetzina +22 · 1 citation
   Medicine · Social Sciences · Economics, Econometrics and Finance · #Chronic Myeloid Leukemia Treatments #Health, Education, and Cultural Studies #Economic and Financial Impacts of Cancer
3. 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
   2025/07/11 by Jane F. Apperley, Dragana Milojković, Dragana Milojkovic +50 · 1 citation
   Medicine · #Chronic Myeloid Leukemia Treatments #Eosinophilic Disorders and Syndromes #Chronic Lymphocytic Leukemia Research
4. Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
   2024/09/23 by Klaus Geissler, Klaus Geißler, Zdenek Koristek +23 · 9 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Acute Myeloid Leukemia Research #Acute Lymphoblastic Leukemia research #Retinoids in leukemia and cellular processes